Mumbai | 02-Oct-2025, 12:15 IST — Filed via NSE corporate actions
Shilpa Medicare Ltd (NSE: SHILPAMED) has announced a 1:1 bonus issue, with the ex-date fixed as October 3, 2025. The corporate action means that for every one equity share held, eligible shareholders will receive one additional share, effectively doubling the number of outstanding shares.
The record date will follow to determine shareholder eligibility, and the allotment of bonus shares will take place thereafter. The move is aimed at rewarding shareholders and improving liquidity in the counter, a practice commonly adopted by companies looking to broaden their retail investor base. <div class=”source-box”> <strong>Source:</strong> <a href=”https://www.nseindia.com” rel=”nofollow”>NSE corporate filing (SHILPAMED)</a> | Published: 02-Oct-2025, 12:15 IST </div>
Key Bonus Details
Why It Matters
- Shareholder reward: A 1:1 bonus effectively doubles the shares held, without changing overall investment value immediately.
- Liquidity boost: By increasing the number of outstanding shares, trading volumes typically see an uptick, improving retail participation.
- Market signaling: Bonus issues are often seen as management’s confidence in the company’s growth trajectory.
Market Context
Shilpa Medicare, engaged in formulations and oncology APIs, has been expanding its product pipeline and scaling exports. The bonus issue adds to shareholder incentives at a time when pharma sector valuations are under watch.
The ex-date of Oct 3 means that trades executed on or after this date will not be eligible for the bonus entitlement. Investors must hold shares as of the record date to receive the allotment.
While the bonus does not change fundamentals, it is expected to enhance liquidity and retail visibility for Shilpa Medicare. The street will now focus on the company’s Q2 FY25 results, R&D progress, and export growth trajectory to gauge medium-term performance.
| Metric | Value | Metric | Value |
|---|---|---|---|
| Mkt Cap | ₹7.64K Cr | P/E Ratio | 68.59 |
| 52-Week High | ₹1,000.00 | 52-Week Low | ₹555.00 |
| Dividend Yield | 0.13% | Qtrly Div Amt | ₹0.25 |
